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i\ii~;;~n Oncolgg
Universal access to health care requires
insurance reform, says AMAS Painter
Interview

T. PAINTER, M.D., IS VICE PRESIDENT FOR HEALTH POLICY AND PROFESSOR OF MEDICINE
AT THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER; HE WAS VOTED PRESIDENT-ELECT OF
THE AMERICAN MEDICALAsSOCIATION (AM.A) IN JUNE 1992. A NATIONALLY RECOGNIZED EXPERT ON
JOSEPH

CANCER CONTROL, PAINTER HAS TURNED HIS ATTENTION TO A HIGHLY CHARGED POLITICAL AND SOCIAL
DEBATE IN THIS COUNTRY: NATIONAL HEALTH POLICY. HE IS AN ENTHUSIASTIC PROPONENT OF THE

AM.A's

PROPOSAL FOR HEALTH CARE REFORM CALLED HEALTH ACCESS AMERICA.

ONCOLOG CONTRIBUTING EDITOR KATHRYN

L.

p AINTER SPOKE

TO

HALE ABOUT THAT PLAN AND ABOUT HEALTH POLICY

INITIATIVES ON BOTH STATE AND NATIONAL LEVELS.

Q
Joseph T. Painter is vice
president for health policy
at M. D. Anderson and
president-elect of the
American Medical
Association

What is the AMA doing about the current crisis in
health care cost and availability?

A
The AMA has been working on a plan for the last three
years. Our premise is that the status quo is simply not
acceptable, and we want to provide a framework for
health care reform. Our view is that we have the best
health care system in the world, in terms of the quality,
but we need to solve two problems: access and cost.
The access problem is fairly straightforward. Only about
40% of the indigent are now covered by Medicaid; we
propose revising the eligibility standards to include
100% of people at or below the federal poverty line. All
would be eligible for a basic set of benefits. In this way
we believe that we can bring the needy into the system.

- --

- - --

Q
How are the employers going to pay?

A
They'll be required to provide only a basic set of
benefits; this will keep costs down. Built-in tax incentives will encourage smaller businesses to provide this
coverage.

Q
Businesses have already indicated displeasure with
such a plan.

A
A plan like this one must be accompanied by insur- -- --±S-:aa:~,----m[HflEea;n----aE~;vmH-- -- - - -- - ----1--afl~---It-t1R:O}I"fHmh.----:l>~fo
.1
longer can we tolerate individ11al
company ratings such that one catastrophic or seriA
ous chronic illness drives everyone's premium up
The basic benefits would include doctor visits, hospital by, say, 100%. We need to move to broad, commustays, and a variety of other benefits covered by a nity-based ratings; we need to eliminate exclusion
on preexisting conditions. We also need to pool
standard health insurance policy.
groups of small insurers to spread the risk and lower
insurance premiums. Insurance also must be porQ
What about the 24 million people who work but table so that people can change jobs without losing
coverage.
don't have insurance?

Q

-

A
What we're proposing is an expansion of the employer-based system in which both the employer and
employee contribute to the premiums.

MD Anderson Oncolog

'-Doctors don't want to be the
rationers; they'd rather provide
the best possible care
to each patient~
•
Q
What about people who are nnable to get insurance because of medical conditions?

A
State pools could be helpful in providing them insurance at a near-normal rate. Many people should be
eligible through their employers if premiums can be
kept down.

•

•

•

•

for given conditions. Once established, ranges can be
used to evaluate patterns of care. Care that is outside
the range may mean a special circumstance was in
effect, it may mean that the physician is using an
effective but unnecessary standard of care, or it may be
deliberate misuse of the system. Ranges may be a way
of getting professional consensus on cases for which
there isn't universal agreement on a best approach.

Q
Q
So the AMA's policy on health care access is ... ?
A
Very much in favor of universal access by removing the
financial barriers that keep people out of the system.

Q

How would it be monitored in private practice?

A
By the insurers. Rather than trying to decide what
services will be paid for, the insurers could simply look
at the patterns ofa physician's care and evaluate whether
this physician fell outside the range. If outside, the
physician's claims would be examined more closely.

Let's get back to the second problem, cost.

Q
A
That is a much more difficult problem. A big problem
in controlling costs is figuring out the cost ofproviding
a particular service to an individual. AMA supports and
wants to perfect a relative value scale, which would be
used to develop a cost-based payment system. Harvard
has developed such a system, which has now been put
into effect under Medicare. like any new system it has
a lot ofproblems, but once it's perfected it will give us a
solid base for defining the cost of a service.

Q

How much cooperation are you getting from the
insurance industry?

A
They are very interested. They see that once the
relative value scale is perfected and patterns of care are
more easily evaluable, claims can be processed much
more efficiently. Their approval and review systems
would be much simpler. Automation would improve
the efficiency even further.

Q

Is the goal to develop a uniform cost per service?

Isn't administration a huge cost?

A
Yes. Different procedures require different levels ofskill,
judgment, experience, and time. A relative value scale
simply says that if a standard office visit is 1, a coronaiy
bypass might be 100. The relative value is then multiplied by a conversion factor determined through
negotation with the payer to establish the fee.

A
One quarter of all dollars spent on health care go to
administration, including filing insurance claims. Insurance companies are interested in any system that
would simplify their procedures and reduce their costs.

Q
What other factors contribute to escalating costs?

Q
What about the growing volume of care?

A
AMA is also developing "ranges" of appropriate care
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A
Compliance with regulations is a huge cost in health
care. Another is professional liability. Clearly we
can't control the volume of care until we have a
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I

"The American people
are going to have to deal with the
question of how much care we
provide to each person~

I

I

•

I

·..reat of liability control. Professional liability adds
. t.:out $20 billion each year to the cost of health
, 1r e through insurance premiums and defensive
(.edicine.
~nally, we propose that society recognize that the
, ,-!tient has to assume a great deal more ofthe responsi. ,ility for his health. Prevention is the best way to
,~Jtimately reduce health care costs. So we're very
,nuch pushing prevention as a final component.

Q
VVhat about the costs of the high technology?

A
That is one area in which we have not yet been able to
resolve the best way to control costs. And technology
is a driving force behind rising costs. Often we have no
good way of assessing whether a new technology adds
substantially to improvement in health or in the patient's
response. At AMA we have a system in place called
DATTA, which is an acronym for a technology assessment capability. It's being used more and more by
insurers and government groups to decide when a
technology is no longer considered experimental and is
ready for general use. It's proven to be a quite effective
mechanism, but I'm not sure over time whether this
method of pulling together a group of experts and
having them review the technology and make recommendations will ultimately work. It's a complicated
process. Clearly we've got to reduce the demand for
high-technology procedures.

Q
Wasn't the Oregon initiative developed by a broad
community-based group of health care professionals, politicians, business leaders, and ordinary citizens? Aren't they representative of "the American
people"?

I

I

A
The AMA's position on the Oregon proposal is that, if
that's what they choose to do, then let's try it. The
AMA believes, however, that we can build on the
current system, using its strengths and controlling its
weaknesses, to give universal access to health care and
control its costs. Our costs are already beginning to
moderate somewhat compared with those in Canada,
Great Britain, and Germany-their costs are growing at
steeper rates than ours at the moment. We're beginning to see some slowing, but not as much as we want.

I

I

I

Q

I

The employer-funded program is a good idea, but
the money has to come from somewhere. Tax
incentives mean reduced revenue for the federal
government. Where might that money come from?

I

A
I

We agree that, overall, these incentives reduce revenue,
but look at Hawaii. For 20 years the state has required
all employers to provide a basic set of benefits, and
that's worked very well. Nobody's gone under, and the
number of small businesses hasn't suffered. The government has succeeded despite any loss of revenue.

I

I

Q

Q

This gets to rationing, as in the Oregon initiative.

What about the relatively high indigent population
in Hawaii? How are they insured?
I

A
What they've asked in Oregon is, is it better to spend
thousands and thousands of dollars on one heart transplant, or to spend the same amount of money and do
something that will help a lot of people, like prenatal
care? But doctors don't want to be the rationers;
they'd rather provide the best possible care to each
patient. Consequently, I think the American people
are going to have to deal with the question of how
much care we provide to each person.

A
They have a basic set of guaranteed benefits. Everyone
is required to have a card that allows them to see a
physician or be treated at a hospital. The costs have not
gone up astronomically. They've been able to contain
them with normal utilization review.

I

I

Q
Can that model be transferred to other places?
I
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'-Almost all proposals
suggest removing control from
Congress and establishing an
independent commission~
•
A
I think so, as can other plans. There are some 50 bills
now in Congress trying to solve the health care system
jproblem. Almost all proposals suggest removing control from Congress and establishing an independent
commission to guide health policy, modeled after the
federal reserve system. This semi-autonomous body
would take over the cost control, benefits regulation,
and so on, eliminating the jockeying around of congressional committees and other political groups. AMA
favors a market-based system and does not see the
advantages of an independent group over Congress.
So that is where we stand on health care reform. Over
the last couple of years, AMA has gone to 80 or 90 of
the Fortune 500 companies and met with their CEOs.
At first they don't like the employer-funded part ofour
plan. After learning more about it, they begin to see the
necessity and admit that it's not a bad plan. They don't
agree with the plan's every detail. They want to control
costs, but are becoming increasingly disenchanted with
the HMOs; even though HMOs are still all the rage,
employers say that switching to an HMO gives a onetime 6 to 8% reduction in costs, but then costs start
rising again at the same rate. We've met with various
groups to attempt to build a consensus that we can
then push to get adopted. For example, I think everybody agrees now that liability reform is long overdue.

Q
Why is there a hold-up on liability reform?

•

works for resolving health care disputes. It's too costly
and too long. Most liability suits are not for real injury,
but for lack of result. People expect a perfect result
every time, even though every procedure has its risks.
An example is the child who has a disability; the parents
sue the physician who delivered the child. These are
cases that require expert and impartial panels to weigh
the evidence. Ifthey decide there was negligence, then
restitution would be made directly.

Q
Then you're suggesting a physician- and community-based system rather than a court-based system
for resolving these disputes?

A
A court could ultimately be involved if the dispute
resolution system was unable to resolve the claim. An
interesting model has been adopted in Maine, where to
curtail the professional liability problem, the state government asked the Maine Medical Association to develop parameters of care for anesthesia, obstetrics, and
one other specialty. Ifa physician practices within those
parameters, he or she cannot be sued for an adverse
outcome. In clear cases of negligence, error, or substandard care, the physician may have to make a settlement or be sued. We're interested in how that plays
out. It's been in effect about six months.

Q
So the AMA is, in general, very pleased with the
state experiments that are going on?

A
Reform is slow because tort laws vary from state to
state. The trial lawyers are very strong at the state
legislature level. For example, in Texas they dominate
the state Senate, and until recently they dominated the
state Supreme Court. So it's difficult to pass legislation
reforming tort law. On the other hand, it is becoming
clearer to congressional leaders and the administration
that liability adds significantly to health costs and will
continue to do so until the liability threat is removed by
passage of a uniform national tort reform law.
The AMA has developed an alternative dispute resolution system. We don't believe the tort system really

page 4

A
I'm not sure any of them are the right way, but they're
going to give us lots of information on how to do
things and how not to do things. Ultimately, we're
going to have to look at a national solution, although I
don't think most of us favor a single-payer system in
which the federal government takes over.

Q
Such as the Canadian system?

A
I was just in Canada at the meeting of the Canadian
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Medical Association. I learned that in this pmportedly
"federal" system, each province actually has a different
health care approach. Basically the federal government
has eliminated private health insurance and said that
each citizen will get a basic set of benefits. The federal
government pays part ofthe cost, and the provinces pay
the rest. Each province manages its own way. A
general framework is given, and the province is free to
modify it. For example, Newfoundland doesn't have
enough money to cover all its health care needs, but it
seems to accept the system as is. British Columbia,
however, has more money and has chosen to contract
with Washington State to provide some of its more
complex health care services. In the Yukon, some
physicians work only about two weeks out of the
month: there's a cap on how much they can be paid
under the system. So they may work for a month or
two each quarter; when they reach the cap they stop
working. If the hospital spends its budget, a section of
the hospital closes down. What is disturbing to many
physicians is that their system is providing only basic
health services, or what we would consider to be basic.

Q
So your position is that a Canadian-style singlepayer system limits growth and development?

A
Yes. There's little research being done except in the large
medical centers. In Canada, a little over half of the
physicians are family physicians; the emphasis is on
training more family doctors and limiting the number
of specialists. That's probably going to be the subject
of the next big fight up there. Of course, there are
many outside the medical profession who are concerned about the number of physicians and the specialty distribution in this country. They think this is
another component of the health care problem and
should be addressed in any long-term solution.

Q
What about the British system? My impression is
that they conduct research and still provide lowcost, accessible care.

A
Remember there are two parts to that system. There
are the family physicians, who are assigned a certain
number of patients and perform general care, and then
there are the hospital-based specialists. The family
doctor provides only ambulatory care, and only the
specialist provides hospital care. But we're seeing the
same thing there as everywhere else: the costs are
eating them alive. They have a finite budget that is

divided among all the local health boards, which then
dole the money out to the individual physicians on the
basis of the number of patients they see. What they've
said implicitly with their system is that, for example,
people over 45 years old with renal disease will not
receive kidney transplants.

Q
So they've been forced to resort to rationing?

A
They've said that older people with chronic diseases will
be made comfortable but not receive treatments such
as coronary bypasses and so on. These more expensive,
technology-based procedures are not part ofthe system
unless the individual can pay for them. So what is
emerging is the private pay insurance system that their
public system was designed to eliminate.
I was recently at a World Health Organization meeting

in Geneva. We were there to discuss the relationship
between private sector and public sector medicine, and
particularly what can be done to help nations emerging
from communism move from a government-dominated system to a public/private system. All these
countries look to the U.S. as a model, recognizing that
we do have problems with access and costs; they all
want to know how to privatize their system. Clearly,
the problems we are having are not unique to the U.S.;
costs are a problem all over the world as governments
struggle with high demands and limited budgets.

Q
It seems we're moving to a more public system,
while others move to a more private system.

A
The public/private mix has served this nation well;
we need a variety of delivery systems to suit everyone. Choice continues to be an important consideration: choice of system, choice of doctor, and
choice of care. Americans expect and deserve the
best medical care. Health care reform must preserve
the strengths of our system while correcting the
cost and access problems. ■
-~IBRYN

L. HALE

Physicians who desire additional information may write
Dr. Painter at the Office ofVice President for Health Policy,
Box 223, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas
77030, or call (713) 792-2200.
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'- Local ... wound complications
were seen in only 15% of patientsdramatically less than the rates ...
typically reported"
•

Vulvar Tumors
continued from page 8

and from Dr. Phillip DiSaia ofthe University of California at Irvine suggested that patients with small vulvar
cancers might be equally well managed with more
limited resections. Dr. DiSaia recommended limiting
conservative resection to patients with tumors having
diameters ofless than 1. 0 cm and invasion ofless than 5
mm. He advocated local resection ofthe primary cancer
with a 1- to 2-cm margin. After defining the lymphatic
drainage patterns of the vulva, he suggested using the
superficial inguinal lymph nodes as the sentinel group
for lymphatic metastasis. Perioperative morbidity in
patients with conservatively resected tumors was lower
than that seen in radically treated patients, and the
majority of patients reported acceptable postoperative
sexual function.
For the past 10 years, we have used a modified version

Figure 1 . A 2-cm
squamous cancer.
Planned resection
margins of 2 cm were
measured and outlined.
For radical wide
excision, the dissection
is carried to the deep
perinea! fascia. Primary
closure without tension
was easily accomplished.
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ofhis approach and have treated patients with resectable
stage I and II vulvar cancers of larger sizes with wide
excision of the primary tumor. Our radical wide excision employs a gross lateral resection margin of 2 cm
and a deep margin at the level of the perineal fascia
(Figure 1). This represents a curative resection effort
that is considerably less extensive than the classic radical
vulvectomy. Patients with lateral lesions undergo a
unilateral superficial inguinal node dissection, while
those with midline lesions have bilateral superficial groin
dissections. Our therapeutic schema is summarized in
Figure 2.
We recently described our experience with 32 patients treated in this manner. This was a mixed group of
stage I and II patients with tumors of up to 6.5 cm in
diameter and invasion of 1-13 mm. Actuarial 5-year
survival was 84%. Local vulvar wound complications
were seen in only 15% of patients-dramatically less
than the rates of 50% typically reported for radical
vulvectomy. Additional review of a second group of
patients whose vulvar tumors invaded less than 1 mm
has demonstrated that even the superficial groin node
dissection can be safely eliminated in this most favorable
subgroup.

Vulvar reconstructive techniques
We are currently trying to expand the option of
function-conserving surgery to patients with larger and
more advanced tumors (3~ cm). We commonly use
local rhomboid skin flaps to reconstruct the vulva following removal of mid-sized tumors. This versatile
technique can be tailored to cover defects ofmany sizes
and almost any perinea! location. Rhomboid flaps have
been particularly useful in reconstructing the periclitoral
area or osterior erineal bod where rim
closure
without tension is frequently not possible. Larger
gracilis myocutaneous flaps can be employed in the
reconstruction of more extensive vulvar defects created
when tumor resection requires hemivulvectomy or partial removal the distal vagina. Although originally
designed to form a neovagina for patients undergoing
pelvic exenteration, gracilis flaps have also proved to be
well suited for external perinea! reconstruction.
The application of these reconstructive techniques to
the vulva has provided a number ofbenefits. Flaps allow
the surgeon access to an adjacent skin source that can be
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-'Although surgical scars are
unavoidable, a reconstruction that is
well planned and well executed usually
resembles the normal vulva"
•

•

mobilized to cover virtually any defect. This option
eliminates the need for primary linear wound closure:
consequently, the risk of wound breakdown and the
tendency ofthe surgeon to secure suboptimal resection
margins are reduced. Reconstructions using rhomboid
or gracilis flaps result in soft, pliable, naturally padded
' repairs that should help maintain comfortable coital
function. Although surgical scars are unavoidable, a
reconstruction that is well planned and well executed
usually resembles the normal vulva.
Current status

Conservative resection is a safe and acceptable option
for patients with small vulvar tumors (::; 2 cm). In most
patients surgical cure is achieved, and those who develop recurrences in the retained vulvar skin usually can
successfully undergo a second wide excision. Patients
with inguinal node metastases or recurrences are at
greatest risk of death from disease. We approach these
cases by resecting bulky lymph nodes and adding postoperative irradiation. Treatment failures seem to be less
frequent when the radiation field includes the lower
pelvic nodes and the vulva, as well as the groin.
The role of tissue-conserving surgery is less clear in
patients with larger cancers. We believe that control of
the vulvar component depends upon an adequate resection of the primary tumor, and that this can often be

•
accomplished with something less than radical
vulvectomy. The higher rate of treatment failure observed in these patients is usually attributable to the
presence of nodal or distant metastases rather than
uncontrolled primary tumor. An accurate lymph node
assessment, coupled with an individualized radiotherapy
plan, is essential in planning curative treatment for these
women. Patients with systemic metastases are usually
not curable with currently available cytotoxic therapy.
In patients with large vulvar cancers, tissue conservation and the sexual rehabilitation of the patient should
be important considerations. However, additional clinical experience is needed to establish whether less aggressive surgical approaches do not sacrifice the potential for
cure. It also should not be assumed that less aggressive
techniques necessarily improve posttherapy sexual function and body image. Such issues must be prospectively
assessed to confirm clinical impressions. Although cure
is the predominant objective of treatment, an individualized, multi.modality approach that preserves tissue
function warrants a careful, ongoing evaluation. ■
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Figure 2. In the conservative management of
operable vulvar cancer, resection of the
primary tumor is considered separately from
evaluation and treatment of the inguinal
lymph nodes. The vulvar lesion is removed by
radical wide excision. lpsilateral superficial
groin dissection is performed in patients with
lateral tumors, whereas bilateral superficial
dissections are done for midline lesions.
Patients with negative superficial nodes
receive no further treatment. Those with
positive superficial nodes can be treated with
more extensive surgical dissection, irradiation,
or both (reprinted with permission from
Current Opinion in Obstetrics and Gynecology
4:87, 1992).
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Conservative surgery a safe option for
patients with small tumors

Tissue conservation techniques for
patients with vu/var cancer
By Thomas W. Burke, M.D.
Treatment Update

Thomas W. Burke is an
associate professor of
gynecology in the
Department of
Gynecology

Although radical surgery will always play a role in the
management ofgynecologic malignancies, recent trends
have emphasized modifications of traditional therapy
that result in less tissue destruction, fewer operative
complications, and better chances for retaining normal
function. Certainly this is true for the current management of patients with vulvar cancer. Patients with
resectable vulvar cancers have typically been treated by
classic radical vulvectomy and bilateral superficial and
deep inguinal lymphadenectomy. This is an aggressive
operation that removes the primary tumor, all vulvar
skin, and regional lymphatics using an en bloc dissection.
Radical vulvectomy was developed and refined during the 1940s through 1960s as a technique to eliminate bulky, bleeding perinea! tumors and to prevent
groin breakdown and drainage from tumor ulceration
in regional lymph nodes. The operation was a signifi-

cant advance and successfully avoided the morbidity of
uncontrolled vulvar cancer. Much of our understanding of prognosis and tumor spread patterns in patients
with vulvar cancer is based on Dr. Felix Rutledge's
experience at The University ofTexas M . D . Anderson
Cancer Center. His detailed evaluations of over 400
cases established the prognostic significance of tumor
size and inguinal node metastasis. This information has
been incorporated into the modem staging classification ofvulvar cancer. Dr. Rutledge's work also defined
the curative potential of radical vulvectomy. Although
producing excellent long-term smvival rates of 8 5- 90%
in patients with stage I and II disease, the radical
operation is associated with substantial morbidity and a
significant impairment of the patient's body image and
sexual function.
Conservative resection of small cancers
In the late 1970s, preliminary data from the Department ofGynecology at M. D . Anderson Cancer Center
continued on page 6

